You are here

B-MoGen Biotechnologies Inc

Company Information
Address
1621 E Hennepin Ave Suite B-15
Minneapolis, MN 55414-2489
United States



Information

UEI: N/A

# of Employees: 1


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy

    Amount: $1,406,084.00

    Cancer immunotherapy, particularly genetically engineered adoptive T cell transfer, has shown great potential for the treatment of cancer patients. The use of T cells engineered to express a specific ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  2. Development of mitochondrial disease mouse models

    Amount: $224,856.00

    Project Abstract Mitochondria are double membrane bound organelles that are found in all eukaryotic cells and carry a specialized circularkb genomeThere is a group of devastating human genetic disease ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
  3. Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy

    Amount: $218,588.00

    Abstract Cancer immunotherapyparticularly genetically engineered adoptive T cell transferhas shown great potential for the treatment of cancer patientsThe use of T cells engineered to express a specif ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  4. Stable Gene Transfer by RNA Delivery

    Amount: $224,634.00

    Abstract Non viral gene delivery is used in most biomedical laboratories for basic research and for many commercial and medical applications These include basic investigations into gene function mod ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  5. Effective engineering of the mitochondrial genome

    Amount: $224,564.00

    Abstract This proposal leverages our novel unprecedented and unique method for editing the mitochondrial genome B MoGen has exclusive license to this technology This proposal will finally provide ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  6. Next Generation Genome Editing Tools

    Amount: $149,431.44

    This proposal leverages our expertise in genetic engineering in general, our success in multiplex gene editing, and nanoparticle-based gene delivery to achieve targeted base editing of hepatitis B vir ...

    SBIRPhase I2017Department of Defense Defense Advanced Research Projects Agency
US Flag An Official Website of the United States Government